Cypress Point Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$1.39M |
| 2 |
Dimensional US Targeted Value ETF
DFAT
|
+$744K |
| 3 |
Nu Holdings
NU
|
+$718K |
| 4 |
Schwab US REIT ETF
SCHH
|
+$209K |
| 5 |
Tesla
TSLA
|
+$197K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
C4 Therapeutics
CCCC
|
+$2.88M |
| 2 |
Matador Resources
MTDR
|
+$2.77M |
| 3 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$1.57M |
| 4 |
CORZ
Core Scientific, Inc. Common Stock
CORZ
|
+$1.11M |
| 5 |
Palantir
PLTR
|
+$977K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.33% |
| 2 | Consumer Discretionary | 9.72% |
| 3 | Financials | 7.63% |
| 4 | Healthcare | 1.84% |
| 5 | Consumer Staples | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Asana
ASAN
$1.96B
| – | – |
-7,612
| Closed | -$304K |
|
|
27
C4 Therapeutics
CCCC
$389M
| – | – |
-118,573
| Closed | -$2.88M |
|
28
Salesforce
CRM
$154B
| – | – |
-1,543
| Closed | -$328K |
|
29
Guardant Health
GH
$19.1B
| – | – |
-3,272
| Closed | -$217K |
|
|
30
Matador Resources
MTDR
$6.04B
| – | – |
-52,301
| Closed | -$2.77M |
|
31
Schwab US Broad Market ETF
SCHB
$42.3B
| – | – |
-12,258
| Closed | -$218K |
|
32
Upstart Holdings
UPST
$2.55B
| – | – |
-3,942
| Closed | -$430K |
|
|
CORZ
33
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| – | – |
-134,638
| Closed | -$1.11M |
|
|
IBTX
34
DELISTED
Independent Bank Group, Inc.
IBTX
| – | – |
-4,515
| Closed | -$321K |
|
|
REGI
35
DELISTED
Renewable Energy Group, Inc.
REGI
| – | – |
-4,535
| Closed | -$275K |
|
Similar funds
Cypress Point Wealth Management's Q2 2022 Portfolio in Review
As of Q2 2022, Cypress Point Wealth Management held 35 positions worth $57M, down 42% from $98.4M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Cypress Point Wealth Management withdrew a net $10.2M in Q2 2022, closing 12 positions and reducing 10 holdings. Its most notable exit was C4 Therapeutics, an estimated $2.88M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 48% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Cypress Point Wealth Management opened a new position in Dimensional US Targeted Value ETF worth $682K.
- Cypress Point Wealth Management's largest Q2 2022 buy was Dimensional US Targeted Value ETF: 16,955 shares worth $682K.
- Cypress Point Wealth Management added most to Dimensional US Core Equity 2 ETF in Q2 2022, an estimated $1.39M increase.
- Cypress Point Wealth Management's biggest Q2 2022 reduction was Vanguard Ultra-Short Bond ETF, cutting an estimated $1.57M.
- Cypress Point Wealth Management fully exited C4 Therapeutics in Q2 2022, selling an estimated $2.88M.
- Cypress Point Wealth Management's ten largest holdings make up 80% of its $57M portfolio in Q2 2022.
- Cypress Point Wealth Management opened 2 new positions and closed 12 in Q2 2022.
- Cypress Point Wealth Management's portfolio value fell 42% quarter-over-quarter to $57M.
Based on Cypress Point Wealth Management's 13F filing for Q2 2022, filed 8 Aug 2022.